These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 12445249

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The prognostic significance of the immunohistochemical expression of p53, bcl-2, c-erb B-2 and cathepsin-D in ovarian cancer patients receiving platinum with cyclophosphamide or paclitaxel chemotherapy.
    Protopapas A, Diakomanolis E, Bamias A, Milingos S, Markaki S, Papadimitriou C, Dimopoulos AM, Michalas S.
    Eur J Gynaecol Oncol; 2004; 25(2):225-9. PubMed ID: 15032288
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging.
    Skírnisdóttir I, Seidal T, Sorbe B.
    Int J Gynecol Cancer; 2004; 14(2):259-70. PubMed ID: 15086725
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. THE PROGNOSTIC SIGNIFICANCE OF P53, BCL2 AND MIB1 EXPRESSIONS RELATED WITH OTHER CLINICOPATHOLOGICAL VARIABLES IN SEROUS OVARIAN CARCINOMAS. A CLINICOPATHOLOGICAL STUDY IN PERITONEAL FLUIDS.
    Kalogeraki A, Tamiolakis D, Matalliotaki C, Karvela-Kalogeraki I, Karvelas-Kalogerakis M, Segredakis J, Sinatkas V, Matalliotakis I.
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):454-60. PubMed ID: 26204652
    [Abstract] [Full Text] [Related]

  • 8. P53, bcl-2, and bax: their relationship and effect on prognosis in early stage epithelial ovarian carcinoma.
    Skirnisdóttir I, Sorbe B, Seidal T.
    Int J Gynecol Cancer; 2001; 11(2):147-58. PubMed ID: 11328414
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer.
    Baekelandt M, Kristensen GB, Nesland JM, Tropé CG, Holm R.
    J Clin Oncol; 1999 Jul; 17(7):2061. PubMed ID: 10561259
    [Abstract] [Full Text] [Related]

  • 10. DEF6 expression in ovarian carcinoma correlates with poor patient survival.
    Liew PL, Fang CY, Lee YC, Lee YC, Chen CL, Chu JS.
    Diagn Pathol; 2016 Aug 03; 11(1):68. PubMed ID: 27488395
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer.
    Ikeda K, Sakai K, Yamamoto R, Hareyama H, Tsumura N, Watari H, Shimizu M, Minakami H, Sakuragi N.
    Int J Gynecol Cancer; 2003 Aug 03; 13(6):776-84. PubMed ID: 14675314
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M, Zimmermann AK, Wild PJ, Caduff R, von Teichman A, Fink D, Moch H, Noske A.
    Exp Mol Pathol; 2013 Oct 03; 95(2):235-41. PubMed ID: 23965232
    [Abstract] [Full Text] [Related]

  • 17. Activation of c-erbB-2 and prognosis in ovarian carcinoma. Comparison with histologic type, grade, and stage.
    Singleton TP, Perrone T, Oakley G, Niehans GA, Carson L, Cha SS, Strickler JG.
    Cancer; 1994 Mar 01; 73(5):1460-6. PubMed ID: 7906608
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. p53 and bcl-2 in epithelial ovarian carcinoma: their value as prognostic indicators at a median follow-up of 60 months.
    Geisler JP, Geisler HE, Miller GA, Wiemann MC, Zhou Z, Crabtree W.
    Gynecol Oncol; 2000 May 01; 77(2):278-82. PubMed ID: 10785478
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen.
    Kupryjańczyk J, Szymańska T, Madry R, Timorek A, Stelmachów J, Karpińska G, Rembiszewska A, Ziółkowska I, Kraszewska E, Debniak J, Emerich J, Ułańska M, Płuzańska A, Jedryka M, Goluda M, Chudecka-Głaz A, Rzepka-Górska I, Klimek M, Urbański K, Breborowicz J, Zieliński J, Markowska J.
    Br J Cancer; 2003 Mar 24; 88(6):848-54. PubMed ID: 12644821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.